When is Particle Health the better choice?

It is retrieval infrastructure queried through a single bidirectional interface across the national networks, so a developer takes data on demand rather than adopting a platform. The enrichment layer sits on top of genuine interoperability plumbing, which is harder to build than a document reader and harder to replace once embedded. For a company building its own product, an interface is a smaller commitment than a data platform with its own consent model and tenancy design.

When is Zus Health the better choice?

It assembles and maintains the longitudinal record rather than returning a query result, deduplicating and normalising across thousands of provider sites, prescription fills and admission alerts. It publishes a match rate of roughly ninety percent, which is an explicit admission that identity resolution is imperfect, and it links every summarised point to the underlying record. The consent architecture is described in more detail than almost anything in this index, gating third party data on an asserted treatment relationship.

Particle Health vs Zus Health

Last VerifiedAugust 4, 2026

Verdict

Both retrieve clinical data from the national networks and they hand it back in different shapes. Particle is an interface: query the networks through one bidirectional connection, with an enrichment layer on top, which suits a company building its own product and wanting data on demand. Zus is a platform: it assembles and maintains the longitudinal record across thousands of provider sites, prescription fills and admission alerts, deduplicated and normalised, with the most detailed consent architecture in this index and a published match rate that admits its own imperfection. The commitment differs as much as the capability. An interface is easy to leave; a platform whose design property is cross tenant sharing is not, and neither vendor publishes a security attestation for holdings of that size.

Select Particle Health if

It is retrieval infrastructure queried through a single bidirectional interface across the national networks, so a developer takes data on demand rather than adopting a platform.
The enrichment layer sits on top of genuine interoperability plumbing, which is harder to build than a document reader and harder to replace once embedded.
For a company building its own product, an interface is a smaller commitment than a data platform with its own consent model and tenancy design.

Select Zus Health if

It assembles and maintains the longitudinal record rather than returning a query result, deduplicating and normalising across thousands of provider sites, prescription fills and admission alerts.
It publishes a match rate of roughly ninety percent, which is an explicit admission that identity resolution is imperfect, and it links every summarised point to the underlying record.
The consent architecture is described in more detail than almost anything in this index, gating third party data on an asserted treatment relationship.

Attribute Matrix

Side by Side

Axis	P Particle Health	Z Zus Health
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Healthcare Administrative Automation page.

Abstractive Health vs Zus Health→Credo Health vs Zus Health→emtelligent vs Zus Health→Particle Health vs Tennr→Regard vs Zus Health→ThetaRho vs Zus Health→

Disclosure

The architectural difference matters more than the feature comparison: one is a query interface and the other is a multi tenant platform whose central design property is cross tenant data sharing, which means no single tenant deployment is possible by construction and the aggregation risk is inherent rather than incidental. Neither publishes a security attestation or trust centre, which is consequential for platforms holding assembled records for very large patient populations. Neither publishes pricing. Ask both for match rate and for what happens to a record that cannot be confidently resolved to a patient.